Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-17-065657

Options or other derivatives

  • EVP, Chief Financial Officer acquired 72,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bell Graeme · EVP, Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-12-12 Grant or award : show line 1 in the form Stock Option (right to buy) +72,500 72,500 D
Loading xslF345X03/doc4.xml…